在病态骨形成中向纤维细胞:机制和治疗方法
Qianyu Zhang1,2, Qimin Song1,2, Zeyin Li1,2
1School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
Frontiers in cell and developmental biology
|June 10, 2025
概括
纤维细胞驱动异常的骨形成在异型骨化 (HO) 和化脊髓炎 (AS) 等条件下. 针对纤维细胞信号,炎症和衰老,为这些骨疾病提供了潜在的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 骨生物学 骨生物学
- 病理学 病理学 病理学
背景情况:
- 纤维细胞在病态骨形成过程中起着至关重要的作用.
- 异常的骨化状况包括异型骨化 (HO),化脊椎炎 (AS) 和后纵带带骨化 (OPLL).
研究的目的:
- 审查纤维细胞在异常骨形成中的多方面的作用.
- 探索纤维细胞在炎症和机械信号通路中的参与.
- 突出针对纤维细胞介导骨化的潜在治疗策略.
主要方法:
- 文献综述总结了有关纤维细胞在骨病理学中的作用的现有研究.
- 分析涉及的信号通路,包括BMP,TGF-β和Wnt/β-catenin.
- 检查纤维细胞对HO,AS,OPLL,DISH和SSc等疾病的贡献.
主要成果:
- 纤维细胞转化为类似骨质细胞的细胞,有助于骨的形成.
- 衰老纤维细胞分泌Activin A,激活HO中的BMP通路.
- 纤维细胞对AS和OPLL的炎症和机械信号作出反应,促进骨质生成.
结论:
- 纤维细胞是各种病理性骨形成障碍中的关键细胞参与者.
- 准纤维细胞信号通路,衰老和炎症提供了有希望的治疗途径.
- 了解纤维细胞生物学对于开发有效的异常骨化治疗方法至关重要.
相关概念视频
Introduction to Fibroblasts
3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Fractures: Bone Repair
3.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.0K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


